Loading...

Major Indexes

Free Cash Flow

Intercept Pharmaceuticals Inc.

Intercept Pharmaceuticals Inc. (ICPT)

$45.09
1.23 (+2.80%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 1.621.742.7824.95130.96179.81252.00825.852,706.478,869.6429,067.59
Revenue (%)
Operating Cash Flow -28.01-87.74-162.90-342.44-265.40-240.71-236.60-17,016.02-55,764.91-182,752.77-598,917.38
Operating Cash Flow (%)
Capital Expenditure 1.634.645.945.0810.400.161.13718.742,355.447,719.2525,297.53
Capital Expenditure (%)
Free Cash Flow -26.38-83.10-156.97-337.36-255.00-240.54-235.47-16,297.29-53,409.47-175,033.52-573,619.85

FCF Unlevered from cash flow statement